Navigation Links
MHA Announces Pegeen Butterfield, RN as Senior Vice President of Trade Relations
Date:1/6/2009

FLORHAM PARK, N.J., Jan. 6 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA) is pleased to announce that Pegeen Butterfield, RN, has joined MHA, Inc. as the new Senior Vice President of Trade Relations. In this newly created role Pegeen will have executive responsibility for all contracting functions and all wholesaler business partnerships. Michael J. Sicilian, President of MHA, commented, "The creation of this new role within our organization is directly related to the significant growth we have experienced over the last several years. By combining all contracting functions under Pegeen, we will be able to continue to strategically build stronger business partnerships and provide more value for the members we serve."

Pegeen joins MHA after spending the last 9 years working for Medco Health Solutions. Most recently she worked directly with the executive management team focusing on strategic partnerships, leveraging prescription data and developing employer solutions for onsite pharmacy and medical clinics. Previous roles at Medco included provider relations and strategic alliances within Medco's retail network division focusing on retail specialty pharmacy strategy, and development of a Long Term Care Network for Medicare Part D. Her background also includes extensive medical insurance experience in medical policy, utilization management and case management, including creation of a care management subsidiary of Blue Cross Blue Shield. She began her career as a nurse with a focus on rehabilitation medicine specializing in traumatic brain injury. Pegeen's unique combination of skills in relationship management, building creative partnerships, clinical expertise and a diverse healthcare view will allow her to make a major contribution to MHA's continue growth. Added Pegeen, "I am thrilled to be joining the largest alternate site GPO in the country. By creating this role, MHA has demonstrated its commitment to developing new contracting strategies, engaging our wholesaler business partners at the executive level and continuing to bring value to our membership."

Managed Health Care Associates, Inc. (MHA) is the market leading Alternate Site GPO and Long Term Care Pharmacy Network Manager servicing the Independent LTC Pharmacy Industry. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create innovative, customized, web tools and reports, designed to increase savings and promote profitability. Members utilize MHA's services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and food, as well as, network access to the majority of the largest national and regional prescription drug plans managing the Medicare Part D drug benefit. MHA also offers a variety of services to medical supply, pharmaceutical manufacturers and prescription drug plan organizations, including contract administration, marketing, and continuing education. For more information, visit www.mhainc.com.

    For More Information Contact: Angela Elsier
    Director of Marketing
    Managed Health Care Associates, Inc.
    800-642-3020 X 2870
    aelsier@mhainc.com


'/>"/>
SOURCE Managed Health Care Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IMRIS announces first IMRISneuro project in Australia
2. Akrimax Pharmaceuticals Announces Manufacturing Partnership
3. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
4. American Asthma Foundation Announces Breakthrough Discovery
5. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
6. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
7. DiFUSION Technologies Announces Company Launch Focused on Surgical Site Infections (SSIs)
8. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
9. B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking"
10. Alfacell Announces Receipt of NASDAQ Panel Decision
11. Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Katyl Agency, a locally ... and business owners in and around Lackawanna County, is joining Meals On Wheels ... area. , Meals on Wheels of NEPA provides hand-delivered and nutritious meals to ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... All-Star Insurance, ... residential and business clients throughout eastern Texas, is announcing the launch of a new ... Recent breast cancer statistics in the United States reveal that an estimated 252, 710 ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... the Houston area with access to asset protection and financial planning services, is ... aimed at improving the lives of children with cancer and other chronic diseases. ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is proud to ... for 2017. Each year, research and information firm, Castle Connolly, releases their list of ... 2015, this marks the 3rd time that Dr. Canales has been recognized ...
(Date:6/22/2017)... ... , ... Groove Ring is excited to announce they've partnered with Olympic runner ... and all-purpose rings. Whether you’re an athlete, adventurer, professional, or love to venture the ... From the rock face to the auto shop, Groove Ring is the world's first ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: